Hantgo.com

Stay Informed Stay Ahead

Medicine

BioPhorum acquires training organisation Brookwood Global

BioPhorum has announced the acquisition of Brookwood Global, a UK-based provider of training and educational content for professionals operating in the field of clinical research.

BioPhorum has been at the heart of the biopharmaceutical industry for more than 15 years. Trusted by leaders from across the industry, it enables them to work together in non-competitive, confidential settings to seek out solutions for the benefit of all. Its members are united by their drive to save and improve patient outcomes and they recognise BioPhorum as the engine room for change in their industry.

Brookwood Global is a privately owned organisation, based in the UK, that has been delivering professional development solutions in the fields of clinical research and drug safety since 1996. Brookwood has trained more than 100,000 clinical research staff from c. 120 countries worldwide.

On announcing the acquisition, Deborah Kobewka, BioPhorum CEO said: “We are delighted to be joining forces with the team at Brookwood. Their expertise in digital training integrates perfectly with our advanced knowledge of the biopharmaceutical and life sciences industries, creating opportunities for diversification and growth for both organisations.

“The relationship also provides BioPhorum with the opportunity to expand our unique proposition into adjacent and connected segments of the pharmaceutical process/value chain, and to develop new services that will help our members derive maximum value from their relationship with us. We are confident that, with Brookwood’s input, BioPhorum members will be able to reach new audiences with the solutions and tools they develop in our workstreams. The collaborative insights and recommendations generated will be translated into practical, on-the-ground training resources that can be applied in their own organisations and further afield. It’s a win-win for us all”.

Professor Dr David Hutchinson, Founder of Brookwood Global said: “BioPhorum is an amazing collaboration with some of the most influential life sciences companies at its heart. We are excited to be part of that community and to help drive improvements in process and skills across the industry. This is a great opportunity for Brookwood, with some real synergies between our operations, and my colleagues and I look forward to working with everyone at BioPhorum as we extend our collective portfolios and deliver further value to our customers.”

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *

Medicine

Aramex Scoop Sustainability AwardGlobal logistics giant Aramex has been awarded the Sustainability in Distribution award at the recent Distributing Pharmaceuticals UK award event at the Coventry Building Society Arena. The awards night recognised the very best in innovation and sustainability from those that are directly involved in the design, development or distribution of pharmaceuticals – a sector in which Aramex has a significant footprint. Despite being up against fierce competition within their selected category, the judges ruled that Aramex’s unwavering commitment to sustainability, environmental stewardship, and mitigating climate risks were what tipped the scales on the night. Citing a 42% reduction based on scope 1 & 2 and a 25% reduction on scope 3, dependent on supplier commitment, Aramex has since 2006 implemented a multifaceted climate change mitigation strategy with the sole aim of minimising its carbon footprint and improving its impact on the environment. This strategy involves investment into renewable energy projects, commitment to minimising waste and promoting recycling across its network, enhancing energy efficiency across its operations, with initiatives such as ISO 14001 certification, LEED certification for its facilities along with further energy efficiency projects to drive down usage. Reduced water consumption, route optimisation projects to reduce fuel consumption and emissions, and a commitment to gradually transitioning its fleet to electric and low-emission vehicles have also been put in place. Aramex has also implemented its Future Vehicle Program which explores innovative solutions such as autonomous vehicles and drone deliveries to enhance efficiency and reduce environmental impact in the years to come. Ronan Kitchin who heads up the Life Science and Healthcare division at Aramex UK commented: “We are delighted to have been recognised by Distributing Pharmaceuticals at their recent award event for our work in driving sustainability initiatives throughout our distribution services – a commitment which we have made significant strides towards over the past two decades. “With a legacy of championing sustainability, our environmental and climate change mitigation strategy looks to deliver tangible and positive changes in reducing emissions across the entire business – whether that be in our efforts to minimise waste or reducing fuel consumption. Ensuring our footprint is kept at a minimum where possible is at the top of our agenda and we couldn’t be prouder that this has been recognised by an independent panel of respected industry experts within the pharmaceutical industry – a sector within which we have a long and proud history serving. “Ultimately, it’s about doing the right thing. The world is undergoing a rate of change which is incomparable to anything humankind has ever faced before and therefore all need to play their part if the collective goal of defeating the worsening climate crisis is to be achieved. A huge thanks must therefore go out to all team members across the Aramex network who have each played a part in helping the company make such incredible inroads in its own sustainability goals.”